End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
74.3 TWD | +0.41% | -0.93% | +79.90% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 179 | 100.0 % | 272 | 100.0 % | +51.90% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 179 | 100.0 % | 272 | 100.0 % | +51.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Hsueh Chun Wu
DFI | Director of Finance/CFO | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jy Gang Ger
BRD | Director/Board Member | - | 16-06-22 |
Chih Cheng Chang
BRD | Director/Board Member | - | 13-10-24 |
Han Fei Lin
CHM | Chairman | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
Chen Chung Chang
BRD | Director/Board Member | - | 03-06-24 |
Chi-Chow Liao
BRD | Director/Board Member | - | 13-10-24 |
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Tzu Cheng Chang
BRD | Director/Board Member | - | - |
Chao Long Chen
BRD | Director/Board Member | - | 22-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 121,865,775 | 53,103,775 ( 43.58 %) | 0 | 43.58 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+79.90% | 278M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 1799 Stock
- Company Easywell Biomedicals, Inc.